IL33 and gastric neoplasm: A recent study identified an IL-33/mast cell/M2 macrophage axis promoting gastric tumorigenesis, where genetic deficiency in either ST2, mast cells or in vivo depletion of macrophages all restricted gastric tumour growth in gp130F/F mice.